Medivolve Stock Performance
| MEDVF Stock | USD 0 0.00 0.00% |
The company secures a Beta (Market Risk) of 0.0, which conveys not very significant fluctuations relative to the market. the returns on MARKET and Medivolve are completely uncorrelated.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Medivolve has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Medivolve is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
| Begin Period Cash Flow | 851.4 K | |
| Total Cashflows From Investing Activities | -626.3 K | |
| Free Cash Flow | -9.4 M |
Medivolve |
Medivolve Relative Risk vs. Return Landscape
If you would invest 0.20 in Medivolve on September 29, 2025 and sell it today you would earn a total of 0.00 from holding Medivolve or generate 0.0% return on investment over 90 days. Medivolve is currently producing negative expected returns and takes up 0.0% volatility of returns over 90 trading days. Put another way, 0% of traded pink sheets are less volatile than Medivolve, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Medivolve Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Medivolve's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Medivolve, and traders can use it to determine the average amount a Medivolve's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| MEDVF |
Based on monthly moving average Medivolve is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Medivolve by adding Medivolve to a well-diversified portfolio.
Medivolve Fundamentals Growth
Medivolve Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Medivolve, and Medivolve fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Medivolve Pink Sheet performance.
| Return On Equity | -1.25 | |||
| Return On Asset | 0.0165 | |||
| Profit Margin | (0.11) % | |||
| Operating Margin | 0.01 % | |||
| Current Valuation | (972.47 K) | |||
| Shares Outstanding | 27.02 M | |||
| Price To Earning | 0.37 X | |||
| Price To Book | 0.76 X | |||
| Price To Sales | 0.65 X | |||
| Revenue | 86.82 M | |||
| EBITDA | 5.15 M | |||
| Cash And Equivalents | 5.8 M | |||
| Cash Per Share | 0.01 X | |||
| Total Debt | 965.43 K | |||
| Debt To Equity | 0.14 % | |||
| Book Value Per Share | 0.18 X | |||
| Cash Flow From Operations | (9.32 M) | |||
| Earnings Per Share | 0.04 X | |||
| Total Asset | 59.3 M | |||
About Medivolve Performance
By analyzing Medivolve's fundamental ratios, stakeholders can gain valuable insights into Medivolve's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Medivolve has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Medivolve has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
It is a social-impact investment focused company Investing resources, funds and bandwidth for the betterment of the human condition through medical sciences, climate change and technology. Copper One Inc. was incorporated in 2005 and is headquartered in Toronto, Canada. Medivolve operates under Diagnostics Research classification in the United States and is traded on OTC Exchange. It employs 210 people.Things to note about Medivolve performance evaluation
Checking the ongoing alerts about Medivolve for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Medivolve help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Medivolve generated a negative expected return over the last 90 days | |
| Medivolve has some characteristics of a very speculative penny stock | |
| Medivolve has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 86.82 M. Net Loss for the year was (6.61 M) with profit before overhead, payroll, taxes, and interest of 36.57 M. | |
| Medivolve has accumulated about 5.8 M in cash with (9.32 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 12.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing Medivolve's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Medivolve's stock is overvalued or undervalued compared to its peers.
- Examining Medivolve's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Medivolve's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Medivolve's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Medivolve's pink sheet. These opinions can provide insight into Medivolve's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Medivolve Pink Sheet analysis
When running Medivolve's price analysis, check to measure Medivolve's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medivolve is operating at the current time. Most of Medivolve's value examination focuses on studying past and present price action to predict the probability of Medivolve's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medivolve's price. Additionally, you may evaluate how the addition of Medivolve to your portfolios can decrease your overall portfolio volatility.
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |